How to Help Your Patients Find Pyridium in Stock: A Provider's Guide

A patient calls your office: they've been to two pharmacies and neither one has phenazopyridine in stock. They're in significant discomfort, their antibiotic won't start working for another 24 hours, and they need that urinary analgesic now. What do you tell them?

This scenario comes up more often than it should. While phenazopyridine is not in a national shortage, localized pharmacy stock gaps create real barriers for patients in acute pain. This guide gives you and your team a clear protocol to handle these situations efficiently.

Why Phenazopyridine Is Frequently Out of Stock at Individual Pharmacies

Understanding the cause helps you counsel patients and write prescriptions more effectively:

Short-course use (2 days) means pharmacies stock minimal quantities and reorder infrequently

The branded Pyridium is no longer marketed in the U.S., which can cause pharmacy system confusion

Rx-strength (200 mg) and OTC-strength (95–99.5 mg) are stocked in separate systems and areas of the store

Seasonal UTI demand spikes can quickly deplete local pharmacy stock

Step 1: Optimize How You Write the Prescription

Small changes to how you write phenazopyridine prescriptions can meaningfully improve fill rates:

Use the generic name: Write "phenazopyridine HCl 200 mg" — not "Pyridium" — to avoid brand-name confusion in pharmacy dispensing systems.

Authorize OTC substitution: Add "OTC phenazopyridine acceptable if Rx strength unavailable" to the prescription or instruct your staff to tell patients this at checkout.

Direct to high-volume pharmacies: Walmart, Costco, and Target tend to stock larger quantities than small independents.

Consider e-prescribing to multiple options: If your EHR supports it, let the patient choose from a couple of pharmacy options so they can check availability.

Step 2: Proactively Counsel Patients at the Point of Care

When you or your team prescribes phenazopyridine, send the patient home with this quick guidance:

Check the OTC aisle first — AZO Urinary Pain Relief (phenazopyridine 95–99.5 mg) is the same active ingredient and available at CVS, Walgreens, Walmart, Target, and most grocery stores without a prescription.

If they need the prescription strength, direct them to medfinder — a service that calls pharmacies in their area to find which ones have the medication in stock.

Remind them that their pharmacist can transfer the prescription to a nearby location at no cost.

Ibuprofen (if not contraindicated) or acetaminophen can provide partial pain relief while they locate phenazopyridine.

Step 3: Know When Phenazopyridine Is Contraindicated

Not every patient is a candidate for phenazopyridine. Review contraindications before prescribing:

Renal insufficiency: Phenazopyridine is renally excreted (~65% unchanged). Drug accumulation causes toxic manifestations — including yellowing of the skin and sclera. Screen geriatric patients carefully given the higher prevalence of decreased renal function.

G6PD deficiency: Associated with oxidative hemolysis when phenazopyridine is administered.

Severe hepatitis: Contraindicated due to potential hepatic accumulation.

Methemoglobinemia risk: Rare but elevated when phenazopyridine is combined with prilocaine, benzocaine, or dapsone.

A Note on Urine Test Interference

Phenazopyridine's azo dye properties interfere with urinalysis tests that rely on color reactions or spectrometry. If a patient has a urine culture or urinalysis ordered, the specimen should ideally be collected before starting phenazopyridine, or the lab should be informed that the patient is taking it. Document this in your post-visit instructions.

How medfinder Supports Your Patients

medfinder is a patient-facing service that calls pharmacies near the patient to check which ones can fill a specific prescription. It works for all medications — not just drugs in formal shortage. For patients without transportation or in areas with limited pharmacy options, this can be especially valuable. Learn more at medfinder.com/providers. For more clinical background on the availability issue, see our provider shortage overview.